Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07293260RecruitingPhase 3
Olpasiran heart scan study for high Lp(a) patients
This study tests if a medication called olpasiran can lower a type of fat in your blood called Lp(a), which is linked to heart problems. You take the medicine or a placebo and get a special heart scan to see changes in your arteries.
Bridgeport, ConnecticutAges 35–80 - NCT06126822RecruitingPhase 3
Study of Ebola vaccine booster in previously vaccinated adults
This study tests if a booster dose of one of two Ebola vaccines (Ervebo® or Zabdeno®) is safe and works well in people who already got an Ebola vaccine more than 4 months ago. It's especially for people living in the Democratic Republic of Congo (DRC) who may have been vaccinated before and might need a stronger, longer-lasting immune response.
GomaAges 18–50 - NCT06879847Recruiting
Clinical trial of radiation and chemotherapy before stem cell transplant for hard-to-treat AML
This trial tests a combination of total body irradiation and two chemotherapy drugs (busulfan and melphalan) given before a stem cell transplant. It is for people with acute myeloid leukemia that has come back or not responded to standard treatment.
Suzhou, JiangsuAges 14–70 - NCT06879834Recruiting
AI software for diabetic eye screening
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
OdesaAges 18–90 - NCT05777447Recruiting
Study for infected aorta/iliac aneurysm after in-place repair
This study looks at treatment outcomes for people whose aorta or iliac artery aneurysm became infected (a “mycotic” aneurysm) and who were treated with an in-place repair. It may help doctors understand the best way to manage this rare condition after surgery.
Roma, RMAges 18 years+ - NCT05777460Recruiting
Testing custom-made devices for the thoracic aorta
This trial looks at the longer-term results of custom-made devices placed in the thoracic aorta (the main blood vessel in the chest). It may help patients learn how well these tailored devices work over time.
Roma, RMAges 18 years+ - NCT06740396Recruiting
Depression in heart disease patients in Baghdad
This study looks at how common depression is in people with coronary artery disease and how severe it is. If you have heart disease and are being treated at a hospital in Baghdad, you can help doctors understand the link between heart health and mental health.
BaghdadAges 18 years+ - NCT06877195Recruiting
Vein graft support mesh for bypass surgery
This trial tests a mesh wrap that supports the vein grafts used in bypass surgery. It may help those grafts stay open longer, especially for the right side of the heart.
Roma, RomaAges Any age - NCT06882265Recruiting
Remote monitoring for people on long-term oxygen therapy
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
São Paulo, São PauloAges 18–85 - NCT05785546Recruiting
Build a wheelchair seat change prediction score
This study looks at how your wheelchair seating setup changes over time and uses that information to create a prediction score. The goal is to help the clinical team better decide when a seat adjustment might be needed.
GarchesAges 18 years+ - NCT06335095Recruiting
Spine disease and walking analysis study for adults 50–85
This study looks at how spine conditions affect the way people walk. Researchers will analyze your walking patterns to better understand spine disease and help guide future treatments.
LisbonAges 50–85 - NCT07281456RecruitingPhase 2
Testing a new oral drug for Sjögren's disease safety
This study tests the safety of a daily pill called Tofacitinib for adults with mild-to-moderate Sjögren's disease. It aims to see if this drug helps manage symptoms when other treatments haven't worked well.
Bethesda, MarylandAges 18–75 - NCT07279467Recruiting
Peanut allergy food challenge biomarker study
This study aims to identify markers in the blood that could help predict how severe a peanut allergy reaction might be. If you qualify, your child will undergo a supervised peanut challenge to see how their body responds.
Little Rock, ArkansasAges 1–17 - NCT06660602Recruiting
Brain function check before and after heart surgery
This study checks how well your brain works before and after heart surgery. It uses safe tests like a CT scan and an EEG to see if surgery affects brain function.
BeijingAges 18–80 - NCT07284810Enrolling by invitation
Tracking daily function and quality of life with the Cionic Neural Sleeve
This trial asks new users of the Cionic Neural Sleeve to answer questions about how they move and feel in daily life. It helps understand if the device makes a difference in function and quality of life.
San Francisco, CaliforniaAges 22 years+ - NCT07285655RecruitingPhase 3
Study of L606 for lung disease with high blood pressure in the lungs
This trial tests a new treatment called L606 for people who have both a type of lung disease (ILD) and high blood pressure in the lungs (PH). The goal is to see if it is safe and helps with exercise and breathing.
Phoenix, ArizonaAges 18–80 - NCT07284784RecruitingPhase 2/Phase 3
Buntanetap for Parkinson's disease study
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Birmingham, AlabamaAges 40–85 - NCT07282665RecruitingPhase 3
Vaccine to prevent C. difficile infection in adults 65 and older
This study tests a vaccine that may help protect against a serious gut infection called C. difficile, which often happens after antibiotics or hospital stays. If you are 65 or older and have certain health conditions or recent antibiotic use, you may be able to join.
Athens, AlabamaAges 65 years+ - NCT07283835RecruitingPhase 2
Study of Cretostimogene for non-muscle invasive bladder cancer
This trial tests a new drug, Cretostimogene, for people with a type of bladder cancer that hasn't spread into the muscle layer (non-muscle invasive) and has not responded to standard BCG treatment. The goal is to see if this drug can help control the cancer and avoid the need for bladder removal surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months - NCT06882954Recruiting
Managing Asymptomatic Carotid Stenosis
This trial studies the best way to treat people who have a high-grade blockage in their carotid artery but no symptoms. It focuses on blockages greater than 80% with signs of unstable plaque to prevent future strokes.
Roma, RMAges 18 years+ - NCT07284290RecruitingPhase 4
Brain imaging, thinking, and medication study for Lewy body dementia
This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.
Richmond, VirginiaAges 50–89 - NCT07279870Recruiting
Comparing heart pacing methods for patients with heart block
This study compares two ways to pace the heart in people who have a slow or blocked heart rhythm. The goal is to find which method works better for patients with certain types of heart block.
BariAges 18 years+ - NCT07284082Recruiting
How Does Menopause and HIV Affect Heart Health in Women?
This study looks at how menopause and HIV together might affect a woman's risk for heart disease. If you are a woman with HIV and are either premenopausal, perimenopausal, or postmenopausal, the researchers want to see if the combination of HIV and menopause creates a higher risk.
San Francisco, CaliforniaAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.